Capitolis Liquid Global Markets LLC purchased a new stake in shares of CME Group Inc. (NASDAQ:CME - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 29,000 shares of the financial services provider's stock, valued at approximately $6,735,000.
Several other institutional investors also recently modified their holdings of the business. New Age Alpha Advisors LLC grew its position in CME Group by 50.0% in the 4th quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider's stock worth $30,000 after purchasing an additional 43 shares in the last quarter. Avidian Wealth Enterprises LLC lifted its holdings in shares of CME Group by 2.6% in the fourth quarter. Avidian Wealth Enterprises LLC now owns 1,769 shares of the financial services provider's stock worth $411,000 after buying an additional 45 shares in the last quarter. TFC Financial Management Inc. increased its holdings in shares of CME Group by 8.4% in the fourth quarter. TFC Financial Management Inc. now owns 592 shares of the financial services provider's stock worth $137,000 after purchasing an additional 46 shares during the period. Waldron Private Wealth LLC raised its stake in CME Group by 2.0% in the fourth quarter. Waldron Private Wealth LLC now owns 2,362 shares of the financial services provider's stock valued at $549,000 after purchasing an additional 47 shares in the last quarter. Finally, Venturi Wealth Management LLC raised its position in shares of CME Group by 12.1% during the 4th quarter. Venturi Wealth Management LLC now owns 437 shares of the financial services provider's stock valued at $101,000 after buying an additional 47 shares in the last quarter. Institutional investors and hedge funds own 87.75% of the company's stock.
Analyst Ratings Changes
CME has been the subject of several analyst reports. JPMorgan Chase & Co. dropped their target price on CME Group from $223.00 to $211.00 and set an "underweight" rating for the company in a report on Thursday, April 24th. Royal Bank of Canada restated a "sector perform" rating and set a $269.00 price target on shares of CME Group in a research report on Thursday, April 3rd. Barclays raised their price target on CME Group from $279.00 to $283.00 and gave the company an "equal weight" rating in a report on Wednesday, April 23rd. Keefe, Bruyette & Woods lifted their target price on shares of CME Group from $265.00 to $273.00 and gave the stock a "market perform" rating in a report on Thursday, April 24th. Finally, Erste Group Bank upgraded shares of CME Group to a "strong-buy" rating in a report on Monday, March 17th. Three research analysts have rated the stock with a sell rating, seven have given a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Hold" and an average target price of $256.80.
Check Out Our Latest Report on CME
CME Group Stock Performance
Shares of NASDAQ:CME opened at $282.56 on Tuesday. CME Group Inc. has a 52 week low of $190.70 and a 52 week high of $284.00. The company has a quick ratio of 1.02, a current ratio of 1.01 and a debt-to-equity ratio of 0.10. The firm has a fifty day simple moving average of $262.03 and a two-hundred day simple moving average of $244.22. The stock has a market capitalization of $101.82 billion, a P/E ratio of 29.22, a PEG ratio of 6.76 and a beta of 0.45.
CME Group (NASDAQ:CME - Get Free Report) last posted its quarterly earnings data on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share for the quarter, beating analysts' consensus estimates of $2.61 by $0.19. The business had revenue of $1.64 billion for the quarter, compared to analysts' expectations of $1.56 billion. CME Group had a net margin of 57.52% and a return on equity of 13.62%. The business's revenue was up 10.4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $2.50 earnings per share. On average, analysts expect that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.
CME Group Increases Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, March 26th. Investors of record on Friday, March 7th were issued a dividend of $1.25 per share. The ex-dividend date was Friday, March 7th. This represents a $5.00 dividend on an annualized basis and a yield of 1.77%. This is a boost from CME Group's previous quarterly dividend of $1.15. CME Group's payout ratio is presently 50.30%.
Insiders Place Their Bets
In other news, Director Dennis Suskind sold 1,000 shares of the stock in a transaction on Tuesday, April 29th. The stock was sold at an average price of $271.28, for a total transaction of $271,280.00. Following the transaction, the director now owns 2,915 shares of the company's stock, valued at approximately $790,781.20. This represents a 25.54 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Hilda Harris Piell sold 3,984 shares of the firm's stock in a transaction dated Thursday, February 27th. The shares were sold at an average price of $250.47, for a total transaction of $997,872.48. Following the transaction, the insider now directly owns 27,046 shares in the company, valued at $6,774,211.62. This trade represents a 12.84 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 30,076 shares of company stock worth $7,670,976 over the last quarter. Company insiders own 0.30% of the company's stock.
About CME Group
(
Free Report)
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Featured Articles
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.